REVIVE Prospective Registry Cohort Study

Part of paid clinical trials in Sacramento, California.

Sponsor
Peter Belafsky, MD
Study ID
NCT07429890
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Oropharyngeal Dysphagia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention. — OTHER
    Participants are followed observationally to collect long-term safety and effectiveness data after prior receipt of iltamiocel in the separate Revive clinical trial; no intervention is administered as part of this registry. Long-term safety outcomes and efficacy will be separated in analysis \& reporting

Study Details

The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.

Key Dates

Start date
Apr 30, 2026
Status verified
Feb 2026
Primary completion
Jun 30, 2031
Completion
Jun 30, 2032

Study Design

Enrollment
31 participants (estimated)

Arms

  • Arm: Tongue Dysphagia Oropharyngeal Cancer
    Patients with Oropharyngeal cancer who have received Iltamiocel as part of REVIVE Clinical Study

Primary Outcome Measure

Number of Participants With Iltamiocel-Related Adverse Events and Serious Adverse Events [ Time Frame: From baseline through 5 years of follow-up, assessed annually ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
UC Davis Medical CenterSacramentoCalifornia95817
Peter Belafsky, MD
[email protected]
916-734-2801
Maggie Kuhn, MD
[email protected]
916734-2801
Peter Belafsky, MD (PRINCIPAL_INVESTIGATOR)
Maggie Kuhn, MD (SUB_INVESTIGATOR)
UC SanFrancisco Medical CenterSan FranciscoCalifornia94115
Clark Rosen, MD
[email protected]
415-885-7700
Yue Ma, MD
[email protected]
415-885-7700

Find similar trials in Sacramento, CA

By research site
UC Davis Medical Center· Sacramento, CAUC SanFrancisco Medical Center· San Francisco, CA

Related Studies